Search for: "Hatch v. Hatch"
Results 101 - 120
of 1,137
Sorted by Relevance
|
Sort by Date
4 May 2016, 4:00 am
The individual, employed by the New York City Housing Authority, had violated the Authority's written policy prohibiting its staff members running for political office in a partisan election.Noting that “It is well settled that "[v]iolation of an employer's reasonable policies may constitute disqualifying misconduct," the Appellate Division said that the Authority’s guidelines were established “to assure compliance with the Hatch Act (5… [read post]
14 Sep 2006, 3:30 am
(Merck KGaA v. [read post]
21 Feb 2007, 1:22 pm
In Marrama v. [read post]
21 Jul 2015, 8:25 am
Amgen v. [read post]
29 Mar 2007, 9:27 pm
By Sherri Oslick --- In a case testing the interplay between terminal disclaimers and patent term extensions under the Hatch-Waxman Act, the Federal Circuit, in affirming the judgment of the district court, held that patent term extensions could - nay should - be applied to terminally disclaimed patents, leaving Merck's... [read post]
14 Apr 2018, 11:46 am
” Ferring B.V. v. [read post]
24 Mar 2013, 9:56 pm
Actavis (previously FTC v. [read post]
3 Nov 2010, 6:55 am
Mensing (09-993) and Actavis Elizabeth, LLC v. [read post]
24 Apr 2012, 9:59 pm
Noonan -- On April 17th, the Supreme Court overturned a Federal Circuit decision construing statutory language involving the 2003 Medicare Prescription Drug Improvement and Modernization Act, which amended the 1984 Drug Price Competition and Patent Term Restoration Act (colloquially known as the Hatch-Waxman Act). [read post]
19 Dec 2014, 6:40 am
" AstraZeneca AB v. [read post]
9 Feb 2023, 9:44 am
Hatch & Bailey Co. [read post]
15 Sep 2008, 7:22 pm
More on Janssen Pharmaceutica, N.V. v. [read post]
7 Aug 2008, 9:23 pm
Corp. v. [read post]
29 Apr 2010, 6:37 pm
Enter Stengart v. [read post]
5 Sep 2022, 9:18 am
The conference will offer presentations on the following topics: • Proposed Hatch-Waxman Reform Measures including live audience polling • The Fate of "Skinny Labeling" at the Supreme Court in GSK v Teva • The Relationship between Written Description and Enablement in view of Biogen v Mylan • Patent Eligible Subject Matter after the Supreme Court Denied Cert in American Axle v. [read post]
27 Apr 2010, 9:59 pm
But the statutory language at issue involved the 2003 Medicare Prescription Drug Improvement and Modernization Act, which amended the 1984 Drug Price Competition and Patent Term Restoration Act (colloquially known as the Hatch-Waxman Act), thus raising the opinion's significance. [read post]
17 Dec 2008, 5:54 am
By Donald Zuhn --Last week, the Federal Circuit affirmed a finding of exceptionality and award of $16.8 million in attorneys fees by the District Court for the Southern District of New York in a case involving two Hatch-Waxman challenges to U.S. [read post]
1 May 2012, 10:00 pm
Register for the one hour briefing on Caraco v. [read post]
3 Jul 2018, 7:13 am
On May 23, 2018, the Federal Circuit issued a decision in UCB, Inc. v. [read post]
3 Jul 2018, 7:13 am
On May 23, 2018, the Federal Circuit issued a decision in UCB, Inc. v. [read post]
